Search hospitals > Pennsylvania > State College
Mount Nittany Medical Center
Claim this profileState College, Pennsylvania 16803
Global Leader in Breast Cancer
Global Leader in Cardiovascular Disease
Conducts research for Thyroid Cancer
Conducts research for Lung Cancer
Conducts research for Lymphoma
111 reported clinical trials
6 medical researchers
Summary
Mount Nittany Medical Center is a medical facility located in State College, Pennsylvania. This center is recognized for care of Breast Cancer, Cardiovascular Disease, Thyroid Cancer, Lung Cancer, Lymphoma and other specialties. Mount Nittany Medical Center is involved with conducting 111 clinical trials across 243 conditions. There are 6 research doctors associated with this hospital, such as Kristina S Petersen, PhD, Michelle G. Newman, Ph.D., Penny M Kris-Etherton, PhD, and Suzy Scherf, PhD.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
2Cardiovascular Disease
Global LeaderTop PIs
Kristina S Petersen, PhDPenn State University1 year of reported clinical research
Studies Cardiovascular Disease
2 reported clinical trials
2 drugs studied
Michelle G. Newman, Ph.D.The Pennsylvania State University6 years of reported clinical research
Studies Anxiety Disorder
Studies Social Anxiety Disorder
2 reported clinical trials
4 drugs studied
Penny M Kris-Etherton, PhDPenn State University2 years of reported clinical research
Studies Cardiovascular Disease
1 reported clinical trial
1 drug studied
Suzy Scherf, PhDPennsylvania State University5 years of reported clinical research
Studies Autism Spectrum Disorder
Studies Autism
1 reported clinical trial
2 drugs studied
Clinical Trials running at Mount Nittany Medical Center
Lung Cancer
Childhood Obesity
Obesity
Underage Drinking
Hydrocephalus
ALK Gene Rearrangement
Cardiovascular Disease
Intermittent Claudication
Binge Drinking
Gestational Weight Gain
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mount Nittany Medical Center?
Mount Nittany Medical Center is a medical facility located in State College, Pennsylvania. This center is recognized for care of Breast Cancer, Cardiovascular Disease, Thyroid Cancer, Lung Cancer, Lymphoma and other specialties. Mount Nittany Medical Center is involved with conducting 111 clinical trials across 243 conditions. There are 6 research doctors associated with this hospital, such as Kristina S Petersen, PhD, Michelle G. Newman, Ph.D., Penny M Kris-Etherton, PhD, and Suzy Scherf, PhD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.